Navigation Links
Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
Date:3/5/2008

CHICAGO, March 5 /PRNewswire-USNewswire/ -- A protein that governs development of human embryonic stem cells (hESCs) also inhibits the growth and spread of malignant melanoma, the deadliest skin cancer, Northwestern University researchers have discovered. Metastatic melanoma, which develops from the transformation of skin pigment cells or melanocytes, has a death rate of more than 80 percent and a median survival of less than 7.5 months.

The Northwestern scientists, led by noted researcher Dr. Mary J. C. Hendrix, additionally found that the protein, called Lefty, prevents aggressive breast cancer cells from metastasizing. Death from metastatic breast cancer exceeded 40,000 in 2007, with over 180,000 new cases diagnosed in the United States.

Importantly, Lefty is secreted only in hESCs, and not in any other stem cell type tested - including stem cells isolated from amniotic fluid, cord blood or adult bone marrow - or placental cells.

Results of the study, described in an article in the March 3rd online version of The Proceedings of the National Academy of Sciences, build on an elegant body of research by the Hendrix lab to identify the genes and cellular pathways involved in cancer metastasis.

Dr. Hendrix is president and scientific director of the Children's Memorial Research Center and professor in The Robert H. Lurie Comprehensive Cancer Center of Northwestern University and at the Feinberg School of Medicine. Lynne-Marie Postovit, who was first author on the study and a post-doctoral trainee in the Hendrix lab, is currently an assistant professor at the University of Western Ontario, Canada.

Embryonic stem cells are pluripotent, meaning they can become any of 200-plus cell types in the adult body, depending on the signals they receive from their microenvironment (surrounding cells, tissues and vasculature). During cancer progression, malignant cells also receive and release signals from their microenvironment, c
'/>"/>

SOURCE Northwestern University
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Sticky blood protein yields clues to autism
2. Penn scientists find a protein that inhibits Ebola from reaching out to infect neighboring cells
3. Embryonic Stem Cell Protein Inhibits Melanoma
4. Protein in embryonic stem cells control malignant tumor cells
5. Novel mechanism found that may boost impaired function of leukemia protein
6. Cancer-related protein may play key role in Alzheimers disease
7. Atypical protein kinase C stabilizes SRC-3 levels in breast cancer cells
8. Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
9. Urine protein may be present before hypertension diagnosis in at-risk adolescents
10. VBI, Mayo Clinic investigate link between fungal proteins, innate immunity and asthma
11. Researchers identify and shut down protein that fuels ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... by researchers from the Medical College of Wisconsin, in ... pain and other sickle cell disease complications in children. ... providers and patients were also identified. The study ... of pediatrics at the Medical College and Children,s Research ... presented at the American Society of Hematology meeting Dec. ...
(Date:12/6/2009)... ON. Dec. 6, 2009 A new study provides ... known as venous thromboembolism (VTE). , The condition ... every year, and occurs when an abnormal clot forms ... causing pain and swelling. In some cases, the clot ... through the heart to the lungs, causing a potentially ...
(Date:12/5/2009)... ORLEANSA new three-drug combination has shown in a phase ... effective regimen" in the treatment of patients newly diagnosed ... in bone marrow, say researchers from Dana-Farber Cancer Institute. ... of the 66 patients treated with the drug combination ... "very good partial response rate" in the phase 2 ...
(Date:12/5/2009)... Youngest Babies, This Type of Blood Cancer Is Most ... 5 Pediatric oncologists have identified specific genes, dubbed ... an often-fatal form of leukemia in infants. By more ... predict which infants may benefit from particular treatments. ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... of Britain to highlight the risks of male obesity , ... (PRWEB) ... the country to raise awareness of obesity and to encourage the British ... that many feel embarrassed about, such as bingo wings, wobbly bellies and ...
... ... 2009, VIRGINIA BEACH, Va. Oct. 22, 2008 AMERIGROUP,Corporation (NYSE: ... third,quarter of 2008 was $39.4 million, or $0.74 per diluted share, ... of 2007, a 26.2%,increase., The Company is increasing and narrowing ...
... ),announced today that the jury in the case of ... in Hackensack (Bergen County), found in favor of,the plaintiff ... reviewing,its post-trial options., "We respectfully disagree with the ... which demonstrated that Mrs. Stribling,s,health problems were caused by ...
... and,Chair Emeritus of the University of Louisville,s Department of ... Research (FBR) today announced its board of governors has,unanimously ... the board. Dr.,Polk succeeds the late Dr. Michael E. ... "I am honored to represent the Foundation for Biomedical ...
... of Providing Quality Long Term Care by,$4.2 Billion ... new Eljay, LLC,analysis of Medicaid financing, which was ... projects that Medicaid underfunds the actual,cost of providing ... billion -- with,New York, Illinois, Ohio, Pennsylvania, New ...
... feat could shed light on how cancer develops , , WEDNESDAY, ... stem cell, scientists say they have grown entire prostates in ... of a genetic signature distinguishing stem cells from other types ... issue of Nature . , This information still has ...
Other Medicine News:Health News:Virgin Active Says Leave the Cleavage to the Girls 2Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 2Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 3Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 4Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 5Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 6Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 7Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 8Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 9Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 10Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 11Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 12Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 13Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 14Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 15Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 16Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 17Health News:The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors 2Health News:New National Medicaid Study Underscores Importance of Including State Relief in Stimulus Plan 2Health News:New National Medicaid Study Underscores Importance of Including State Relief in Stimulus Plan 3Health News:New Prostrates Grown From Single Stem Cell 2
(Date:12/4/2009)... Dec. 4 Hospira, Inc. (NYSE: HSP ... company, today announced the launch of its next-generation 50 ... medications and solutions, and now offers a complete size ... environmentally responsible VisIV product. The launch of the 50 ...
(Date:12/4/2009)... Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary ... the initial development and successful testing of a novel ... believes this proprietary optical engine design raises the bar ... designs for swept source OCT light sources. This ...
(Date:12/4/2009)... 4 Drs. Neal Shore and E. David Crawford ... additional analysis of secondary end points of biochemical recurrence ... (monthly degarelix for injection) or monthly leuprolide in prostate ... Prostate cancer patients who received FIRMAGON 240/80 mg/month had ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride 28TELINTRA 28R 29 TLK199 29 Tablets In Pa 4816 1Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride 28TELINTRA 28R 29 TLK199 29 Tablets In Pa 4816 2Antidepressant Use in U S Has Almost Doubled 53537 1Antidepressant Use in U S Has Almost Doubled 53537 2Antidepressant Use in U S Has Almost Doubled 53537 3Boston Scientific to Participate in BMO Capital Markets Health Care Conference 53533 1
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: